Chronic graft-versus-host disease: how can we release Prometheus?

1 Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan; 2 Immunopathogenesis Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS, Bethesda, Maryland; 3 Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts; and 4 Fred Hutchinson Cancer Research Center, Seattle, Washington

• Publication year

  2008

• Venue

  Biology of Blood and Marrow Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbmt.2007.10.023PMID 18162235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of refractory chronic GVHD with rituximab: a GITMO study

  2007cited by this paper
• Induction of organ‐selective CD4+ regulatory T cell homing

  2007cited by this paper
• Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

  2007cited by this paper
• Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

  2007cited by this paper
• CD4+ T Cells Generated De Novo from Donor Hemopoietic Stem Cells Mediate the Evolution from Acute to Chronic Graft-versus-Host Disease1

  2007influential reference
• Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

  2007cited by this paper
• Alteration of the Migratory Behavior of UV-Induced Regulatory T Cells by Tissue-Specific Dendritic Cells1

  2007cited by this paper
• Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.

  2007cited by this paper
• IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice.

  2007cited by this paper
• Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

  2007cited by this paper
• T-cell receptor repertoire usage after allografting differs between CD 4 + CD 25 + regulatory T cells and their CD 4 + CD 25 – counterpart

  2007cited by this paper
• Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

  2007cited by this paper
• Autoimmunity following haematopoietic stem-cell transplantation.

  2007cited by this paper
• Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+CD25+FoxP3+ T cells

  2007cited by this paper
• Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease.

  2007influential reference
• Regulatory T-Cells in the Graft and the Risk of Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation

  2007cited by this paper
• In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

  2007cited by this paper
• Blockade of chronic graft‐versus‐host disease by alloantigen‐induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts

  2007cited by this paper
• T cell regeneration in pediatric allogeneic stem cell transplantation

  2007cited by this paper
• Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients.

  2007cited by this paper
• Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

  2007cited by this paper
• Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

  2007cited by this paper
• Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

  2007cited by this paper
• FOXP3 expression in peripheral blood rapidly recovers and lacks correlation with the occurrence of graft-versus-host disease after allogeneic stem cell transplantation

  2007cited by this paper
• Regulatory dendritic cells protect against cutaneous chronic graft-versus-host disease mediated through CD4+CD25+Foxp3+ regulatory T cells.

  2007cited by this paper
• T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25- counterpart.

  2007cited by this paper
• Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin1

  2007cited by this paper
• Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity

  2006cited by this paper
• CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

  2006cited by this paper
• Potential mechanisms of photopheresis in hematopoietic stem cell transplantation.

  2006cited by this paper
• Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.

  2006cited by this paper
• TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.

  2006cited by this paper
• Schistosoma mansoni infection in eosinophil lineage-ablated mice.

  2006cited by this paper
• Rituximab for steroid-refractory chronic graft-versus-host disease.

  2006cited by this paper
• Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1

  2006cited by this paper
• Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.

  2006cited by this paper
• Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

  2006cited by this paper
• Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

  2006cited by this paper
• IPEX and the role of Foxp3 in the development and function of human Tregs.

  2006cited by this paper
• IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.

  2006cited by this paper
• The IL-21 receptor augments Th2 effector function and alternative macrophage activation.

  2006cited by this paper
• A Potential Side Effect of Cyclosporin A: Inhibition of CD4+CD25+ Regulatory T Cells in Mice

  2006cited by this paper
• Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.

  2006cited by this paper
• Diabetic Patients T Cells of Both Healthy Subjects and Type 1 Regulatory + FOXP 3 + CD 25 + Functional CD 4 Rapamycin Promotes Expansion of Roncarolo

  2006cited by this paper
• Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

  2006cited by this paper
• High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

  2006cited by this paper
• Ex Vivo-Expanded CD4+CD25+ Immunoregulatory T Cells Prevent Graft-versus-Host-Disease by Inhibiting Activation/Differentiation of Pathogenic T Cells1

  2006cited by this paper
• Assessing the potential role of photopheresis in hematopoietic stem cell transplant

  2006cited by this paper
• Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

  2006cited by this paper
• The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.

  2005cited by this paper
• Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

  2005cited by this paper
• Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1

  2005cited by this paper
• Exploiting worm and allergy models to understand Th2 cytokine biology

  2005cited by this paper
• Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.

  2005cited by this paper
• In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

  2005cited by this paper
• In vivo expansion of CD4+CD45RO–CD25+ T cells expressing foxP3 in IL-2-treated HIV-infected patients

  2005cited by this paper
• A function for interleukin 2 in Foxp3-expressing regulatory T cells

  2005cited by this paper
• Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

  2005cited by this paper
• National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

  2005cited by this paper
• Mechanisms of suppression by suppressor T cells

  2005cited by this paper
• Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

  2005cited by this paper
• Cells during Acute Graft-versus-host Disease Regulatory T + Cd25 + Critical Role for Ccr5 in the Function of Donor Cd4

  2005cited by this paper
• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

  2005cited by this paper
• Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.

  2005cited by this paper
• Antigen‐dependent suppression of alloresponses by Foxp3‐induced regulatory T cells in transplantation

  2005cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Numbers of Foxp3-expressing CD4+CD25high T cells do not correlate with the establishment of long-term tolerance after allogeneic stem cell transplantation.

  2005cited by this paper
• Emergent autoimmunity in graft-versus-host disease.

  2005influential reference
• Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

  2004cited by this paper
• Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.

  2004cited by this paper
• Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

  2004cited by this paper
• Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation

  2004cited by this paper
• Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

  2004cited by this paper
• Recipient CD 4 T cells that survive irradiation regulate chronic graft-versus-host disease

  2004cited by this paper
• Association of Foxp3 regulatory gene expression with graft-versus-host disease.

  2004cited by this paper
• Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.

  2004cited by this paper
• L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

  2004cited by this paper
• Fibrotic disease and the T(H)1/T(H)2 paradigm.

  2004influential reference
• Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.

  2004influential reference
• IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent

  2004cited by this paper
• Fibrotic disease and the TH1/TH2 paradigm

  2004cited by this paper
• Target Antigens Determine Graft-versus-Host Disease Phenotype

  2004cited by this paper
• Chronic graft versus host disease

  2004cited by this paper
• Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft‐versus‐host disease after allogeneic bone marrow transplantation

  2004cited by this paper
• Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease.

  2004cited by this paper
• The Pathogenesis of Schistosomiasis Is Controlled by Cooperating IL-10-Producing Innate Effector and Regulatory T Cells

  2004cited by this paper
• Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

  2004cited by this paper
• Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy

  2004cited by this paper
• Supporting Online Material

  2003cited by this paper
• Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Chronic graft-versus-host disease.

  2003cited by this paper
• Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation.

  2003cited by this paper
• Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.

  2003cited by this paper
• Immunoregulatory T Cells : New Therapeutics for Graft-Versus-Host Disease

  2002cited by this paper
• CD4+CD25+ Immunoregulatory T Cells

  2002cited by this paper
• The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

  2002cited by this paper
• Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation

  2002cited by this paper
• Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation1

  2002cited by this paper
• Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.

  2002cited by this paper

• 异基因造血干细胞移植后合并重症肌无力2例报告并文献复习

  2024cites this paper
• Functional Improvement During Prolonged Hospitalization in a Patient With Acute Myeloid Leukemia Utilizing Physical and Occupational Therapy Comanagement

  2022cites this paper
• Hematopoietic stem cell transplantation for primary immune deficiencies

  2020cites this paper
• Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review.

  2017cites this paper
• Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease.

  2016cites this paper
• Defects in Regulatory T Cells Due to CD28 Deficiency Induce a Qualitative Change of Allogeneic Immune Response in Chronic Graft-versus-Host Disease

  2015cites this paper
• Anti–IL-12/23 p40 Antibody Attenuates Experimental Chronic Graft-versus-Host Disease via Suppression of IFN-γ/IL-17–Producing Cells

  2015cites this paper
• Mammalian target of rapamycin inhibitors permit regulatory T cell reconstitution and inhibit experimental chronic graft-versus-host disease.

  2014cites this paper
• Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency

  2014cites this paper
• Immunoproteomic Analysis of Potentially Severe Non‐Graft‐Versus‐Host Disease Hepatitis After Allogenic Bone Marrow Transplantation

  2013cites this paper
• Frequency and Outcome of Graft versus Host Disease after Stem Cell Transplantation: A Six-Year Experience from a Tertiary Care Center in Pakistan

  2013cites this paper
• Chronic graft-versus-host disease: disease biology and novel therapeutic strategies.

  2013cites this paper
• Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17.

  2012cites this paper
• Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by downregulating Th1 and Th17

  2012cites this paper
• Allogeneic Transplantation of Hematopoietic Stem Cells

  2012cites this paper
• Tirosin Kinase Inhibitors in Chronic Graft versus Host Disease: From Bench to Bedside

  2011cites this paper
• Synthetic retinoid Am 80 ameliorates chronic graft-versus-host disease by down-regulating Th 1 and Th 17

  2011cites this paper
• Comorbidities and hematopoietic cell transplantation outcomes.

  2010cites this paper
• The HCT-CI and Other Traditional Risk Factors for HCT Outcomes

  2010cites this paper
• Successful living donor liver transplantation for severe hepatic GVHD histologically resembling autoimmune hepatitis after bone marrow transplantation from the same sibling donor

  2010cites this paper
• Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease

  2009cites this paper
• Survivorship issues in hematopoietic stem cell transplantation.

  2009cites this paper
• In vivo – activated CD 103 CD 4 regulatory T cells ameliorate ongoing chronic graft-versus-host disease

  2008cites this paper
• Stephen chronic GVHD regulatory T cells ameliorate ongoing + CD 4 + activated CD 103 In vivo

  2008cites this paper
• In vivo activated CD103 + CD4 + Regulatory T Cells Ameliorate Ongoing Chronic GVHD

  2008cites this paper
• Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care.

  2008cites this paper
• In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease.

  2007cites this paper